D-0097-2020 Class II Terminated
FDA drug recall D-0097-2020 was initiated by KRS Global Biotechnology, Inc on September 12, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated August 19, 2021). Affected quantity: 152 cartridges.
Recall Details
- Product Type
- Drugs
- Report Date
- October 9, 2019
- Initiation Date
- September 12, 2019
- Termination Date
- August 19, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 152 cartridges
Product Description
Sermorelin Acetate 9 mg/ 3 mL (3 mg/mL),Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487.
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide
Code Information
All lots remaining within expiry.